E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
765-772
Author(s):
Yulin Huang, Rui Chen and Jianwei Zhou
Meet Our Editorial Board Member
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
737-737
Author(s):
Ingunn Holen
Meet Our Editorial Board Member
Journal:
Current Organic Synthesis
Volume:
13
Page:
657-657
Author(s):
Zbigniew J. Witczak
Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Journal:
Current Nanomedicine
Volume:
6
Page:
78-104
Author(s):
Rajendra Awasthi, Isha Pant, Giriraj T Kulkarni, Irene Satiko Kikuchi, Terezinha de Jesus Andreoli Pinto, Kamal Dua and Venkata Ramana Malipeddi
Nutraceuticals, A New Challenge for Medicinal Chemistry
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
3198-3223
Author(s):
Stefania Sut, Valeria Baldan, Marta Faggian, Gregorio Peron and Stefano Dall`Acqua
miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
3136-3153
Author(s):
Michal Wozniak, Aleksandra Mielczarek and Malgorzata Czyz
Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
3171-3188
Author(s):
Jennifer D. Black and Khosrow Rezvani
Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials
Journal:
Clinical Cancer Drugs
Volume:
3
Page:
87-99
Author(s):
Yin Yin, He Wang, Mingjie Lu and Wei Zhu
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Journal:
Clinical Cancer Drugs
Volume:
3
Page:
76-86
Author(s):
Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter
The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4854-4867
Author(s):
Majid Piramoon and Seyed Jalal Hosseinimehr